Table 1 Clinical characteristics of included patients (n = 53).

From: miR-200 family as new potential prognostic factor of overall survival of patients with WHO G2 and WHO G3 brain gliomas

Variable

n

Sex (male)

29 (54.7%)

Age (median; years)

41 (23–67)

TV (median; cm3)

49 (3.375–512)

CTV (median; cm3)

318 (226–420)

Histopatological subtye

 Astrocytoma

30 (56.6%)

 Oligodendroglioma

8 (15.1%)

 Oligoastrocytoma

15 (28.3%)

Grade

 WHO G2

27 (50.9%)

 WHO G3

26 (49.1%)

IDH mutation status

 IDH1 + 

33 (62.3%)

 IDH2 + 

3 (5.7%)

1p19q codeletion

12 (22.6%)

WHO G2

9 (75%)

WHO G3

3 (25%)

Surgery type

 GTR

39 (73.6%)

 STR/biopsy

14 (26.4%)

Back to article page